Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maitane Nuño"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Juan Fernando Arango arteaga, Jairo Legaspi Folgueira, Maria Purificacion Martínez del Prado, Maria Angeles Sala Gonzalez, María Teresa Abad Villar, Laura Sande Sardina, Fernando Pikabea Diaz, Borja Lopez De San Vicente, Maria Teresa Perez hoyos, Covadonga Figaredo Berjano, Maitane Nuño Escolástico, Patricia Novas Vidal, Ane Zumárraga Cuesta, Elena Calvo, Maria Lopez Santillan
Publikováno v:
Cancer Research. 80:P3-14
Introduction: Oncotype DX (ODX) Recurrence Score (RS) is a gene-expression assay that provides prognostic and predictive information in hormonal-receptor positive (HR +), human epidermal growth factor receptor 2 negative (HER2-), axilary lymph node n
Autor:
Fernando Pikabea, P. Martinez Del Prado, N. Dominguez, M. Simon, M.Pérez Hoyos, Maitane Nuño, B. López de San Vicente, María Ángeles Sala, E. Galve
Publikováno v:
Journal of Geriatric Oncology. 10:S56
Autor:
Paula Jaureguibeitia, Fernando Pikabea, Teresa Abad, Ane Zumarraga, Laura Sande, Maria Lopez Santillan, Borja Lopez De San Vicente, Josune Azcuna, E. Galve, Angeles Sala, Juan Fernando Arango, Maitane Nuño, Maria Purificacion Martínez, Patricia Novas, Maria Teresa Perez-Hoyos, Jairo Legaspi
Publikováno v:
Journal of Clinical Oncology. 37:e18073-e18073
e18073 Background: Electronic Medical Records (EMR) were born as a result of medicine digitalization. Healthcare information systems (HIS) hold great value to the workflow management and patient care. New technologies not only allow us work with a fa
Autor:
Maria Teresa Perez hoyos, Maria Lopez Santillan, Juan Fernando Arango, Maitane Nuño, Borja Lopez De San Vicente, Laura Sande, Purificación Martínez, Patricia Novas, María Ángeles Sala, Elena Calvo, Ane Zumarraga, Maria Teresa Abad, Jairo Legaspi, L. Zubiri, Covadonga Figaredo, Fernando Pikabea
Publikováno v:
Journal of Clinical Oncology. 36:e13029-e13029
e13029Background: De novo metastatic breast cancer (dnMBC) represents approximately 6–10% of breast cancer. In luminal-like dnMBC recommendation for endocrine therapy (ET) as first-line treatment i...
Autor:
Ruiz Sarrias, Oskitz1 (AUTHOR) maialen.zabalza@nnbi.es, Martínez del Prado, María Purificación2 (AUTHOR) mariapurificacion.martinezdelprado@osakidetza.eus, Sala Gonzalez, María Ángeles2 (AUTHOR) marian.salagonzalez@osakidetza.eus, Azcuna Sagarduy, Josune2 (AUTHOR) josune.azcunasagarduy@osakidetza.eus, Casado Cuesta, Pablo2 (AUTHOR) pablo.casadocuesta@osakidetza.eus, Figaredo Berjano, Covadonga2 (AUTHOR) covadonga.figaredoberjano@osakidetza.eus, Galve-Calvo, Elena2 (AUTHOR) elena.galvecalvo@osakidetza.eus, López de San Vicente Hernández, Borja2 (AUTHOR) borja.lopezdesanvicentehernandez@osakidetza.eus, López-Santillán, María2 (AUTHOR) maria.lopezsantillan@osakidetza.eus, Nuño Escolástico, Maitane2 (AUTHOR) maitane.nunoescolastico@osakidetza.eus, Sánchez Togneri, Laura2 (AUTHOR) laura.sancheztogneri@osakidetza.eus, Sande Sardina, Laura2 (AUTHOR) laura.sandesardina@osakidetza.eus, Pérez Hoyos, María Teresa2 (AUTHOR) nani.perezhoyos@osakidetza.eus, Abad Villar, María Teresa2 (AUTHOR) mariateresa.abadvillar@osakidetza.eus, Zabalza Zudaire, Maialen1 (AUTHOR), Sayar Beristain, Onintza1 (AUTHOR) oskitz.ruiz@nnbi.es
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2830. 15p.